Alnylam Pharmaceuticals, Inc. (ALNY)
224.03
-3.25
(-1.43%)
USD |
NASDAQ |
Oct 23, 16:00
223.90
-0.13
(-0.06%)
After-Hours: 20:00
Alnylam Pharmaceuticals Total Return Level : 224.03 for Oct. 23, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| October 23, 2026 | 224.03 |
| October 22, 2026 | 227.28 |
| October 21, 2026 | 225.10 |
| October 20, 2026 | 230.71 |
| October 19, 2026 | 233.29 |
| October 16, 2026 | 231.83 |
| October 15, 2026 | 234.03 |
| October 14, 2026 | 224.47 |
| October 13, 2026 | 223.82 |
| October 12, 2026 | 227.02 |
| October 09, 2026 | 232.68 |
| October 08, 2026 | 224.53 |
| October 07, 2026 | 224.41 |
| October 06, 2026 | 223.94 |
| October 05, 2026 | 219.89 |
| October 02, 2026 | 219.72 |
| October 01, 2026 | 231.18 |
| September 30, 2026 | 246.74 |
| September 29, 2026 | 254.07 |
| September 28, 2026 | 255.36 |
| September 25, 2026 | 255.96 |
| September 24, 2026 | 249.59 |
| September 23, 2026 | 246.51 |
| September 22, 2026 | 251.65 |
| September 21, 2026 | 244.32 |
| Date | Value |
|---|---|
| September 18, 2026 | 239.56 |
| September 17, 2026 | 245.51 |
| September 16, 2026 | 239.36 |
| September 15, 2026 | 238.27 |
| September 14, 2026 | 249.99 |
| September 11, 2026 | 248.68 |
| September 10, 2026 | 247.51 |
| September 09, 2026 | 258.00 |
| September 08, 2026 | 260.10 |
| September 04, 2026 | 266.11 |
| September 03, 2026 | 264.50 |
| September 02, 2026 | 267.40 |
| September 01, 2026 | 246.11 |
| August 31, 2026 | 240.69 |
| August 28, 2026 | 237.10 |
| August 27, 2026 | 236.56 |
| August 26, 2026 | 239.00 |
| August 25, 2026 | 240.08 |
| August 24, 2026 | 236.01 |
| August 21, 2026 | 236.22 |
| August 20, 2026 | 229.30 |
| August 19, 2026 | 242.61 |
| August 18, 2026 | 228.61 |
| August 17, 2026 | 224.60 |
| August 14, 2026 | 228.65 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Ionis Pharmaceuticals, Inc. | 42.93 |
| Vertex Pharmaceuticals, Inc. | 523.93 |
| BridgeBio Pharma, Inc. | 68.56 |
| Pfizer Inc. | 100.45 |
| Regeneron Pharmaceuticals, Inc. | 812.48 |